AMZN

208.28

-1.9%↓

TSLA

384.93

+0.2%↑

HD

329.22

-1.47%↓

TM

210.16

-0.74%↓

MCD

309.89

-0.06%↓

AMZN

208.28

-1.9%↓

TSLA

384.93

+0.2%↑

HD

329.22

-1.47%↓

TM

210.16

-0.74%↓

MCD

309.89

-0.06%↓

AMZN

208.28

-1.9%↓

TSLA

384.93

+0.2%↑

HD

329.22

-1.47%↓

TM

210.16

-0.74%↓

MCD

309.89

-0.06%↓

AMZN

208.28

-1.9%↓

TSLA

384.93

+0.2%↑

HD

329.22

-1.47%↓

TM

210.16

-0.74%↓

MCD

309.89

-0.06%↓

AMZN

208.28

-1.9%↓

TSLA

384.93

+0.2%↑

HD

329.22

-1.47%↓

TM

210.16

-0.74%↓

MCD

309.89

-0.06%↓

Search

Skyline Champion Corp

Ouvert

SecteurConsommation cyclique

75.07 -0.48

Résumé

Variation du prix de l'action

24h

Actuel

Min

72.85

Max

76.32

Chiffres clés

By Trading Economics

Revenu

-300K

58M

Ventes

-28M

657M

P/E

Moyenne du Secteur

21.192

33.36

BPA

0.96

Marge bénéficiaire

8.818

Employés

9,000

EBITDA

-13M

80M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+35.95% upside

Dividendes

By Dow Jones

Prochains Résultats

26 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

149M

4.4B

Ouverture précédente

75.55

Clôture précédente

75.07

Sentiment de l'Actualité

By Acuity

50%

50%

140 / 338 Classement par Consumer cyclical

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

Skyline Champion Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

23 mars 2026, 23:47 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23 mars 2026, 22:55 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23 mars 2026, 21:51 UTC

Acquisitions, Fusions, Rachats

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23 mars 2026, 23:59 UTC

Market Talk

Global Equities Roundup: Market Talk

23 mars 2026, 23:59 UTC

Market Talk

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23 mars 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23 mars 2026, 23:37 UTC

Market Talk

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23 mars 2026, 22:42 UTC

Market Talk
Principaux Événements d'Actualité

Global Equities Roundup: Market Talk

23 mars 2026, 22:42 UTC

Market Talk
Principaux Événements d'Actualité

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23 mars 2026, 22:40 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23 mars 2026, 22:23 UTC

Market Talk

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23 mars 2026, 22:22 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23 mars 2026, 22:21 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23 mars 2026, 22:21 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23 mars 2026, 22:20 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23 mars 2026, 22:20 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23 mars 2026, 22:19 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23 mars 2026, 22:19 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23 mars 2026, 22:18 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23 mars 2026, 22:15 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23 mars 2026, 22:08 UTC

Market Talk

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23 mars 2026, 21:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23 mars 2026, 21:42 UTC

Market Talk

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23 mars 2026, 21:32 UTC

Résultats

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23 mars 2026, 21:32 UTC

Résultats

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23 mars 2026, 21:32 UTC

Résultats

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23 mars 2026, 21:10 UTC

Principaux Événements d'Actualité

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23 mars 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

23 mars 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

23 mars 2026, 20:50 UTC

Market Talk
Résultats
Principaux Événements d'Actualité

Basic Materials Roundup: Market Talk

Comparaison

Variation de prix

Skyline Champion Corp prévision

Objectif de Prix

By TipRanks

35.95% hausse

Prévisions sur 12 Mois

Moyen 102.33 USD  35.95%

Haut 111 USD

Bas 95 USD

Basé sur 3 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

3 ratings

3

Achat

0

Maintien

0

Vente

Score Technique

By Trading Central

85.99 / N/ASupport & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Neutral Evidence

Long Terme

Weak Bearish Evidence

Sentiment

By Acuity

140 / 338Classement par Consommation cyclique

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Skyline Champion Corp

Champion Homes, Inc. engages in the production and sale of factory-built housing in North America. The company offers manufactured and modular homes, park models recreational vehicles and cabins, accessory dwelling units, and commercial structures and modular buildings for the multi-family and hospitality sectors. It builds homes under the Skyline Homes, Champion Homes, Genesis Homes, Regional Homes, Athens Park, Dutch Housing, Atlantic Homes, Excel Homes, Homes of Merit, All American Homes, New Era, Redman Homes, ScotBilt Homes, Shore Park, Silvercrest, and Titan Homes in the United States, and Moduline and SRI Homes brand names in western Canada. The company also provides construction services to install and set-up factory-built homes; operates a factory-direct manufactured home retail business under the Regional Homes, Titan Factory Direct, and Champion Homes Center brand names; and offers transportation services to manufactured housing and other industries. The company was formerly known as Skyline Champion Corporation and changed its name to Champion Homes, Inc. in August 2024. The company was founded in 2010 and is headquartered in Troy, Michigan.
help-icon Live chat